Expansion potential L&R USA focuses on wound care and compression therapy with a broad global footprint, suggesting opportunity to cross-sell their Debrisoft, Vliwasorb, Suprasorb lines and Solaris compression garments to hospitals, clinics, and wound care centers in the US market.

Digital partnership Recent collaboration with NursIT Institute for digital wound management indicates openness to integrated digital solutions; leverage this to propose connected wound care workflows, data capture, and telehealth-friendly services to care networks.

Innovation awards Recognition as a finalist and award winner for innovation enhances credibility; use this to position L&R as a premium partner for advanced wound care technologies and secure pilot programs with health systems seeking cutting-edge solutions.

Executive leadership Board and CEO changes in 2025 signal strategic shifts; approach the company with value propositions aligned to refreshed strategic priorities, such as efficiency, digital adoption, and expanded product adoption in US ambulatory and acute care settings.

Small but focused US entity has a lean team (11-50 employees) with a mid-range revenue profile; target mid-market hospitals, specialty clinics, and durable medical equipment distributors that value specialized wound care and compression portfolios for growth opportunities.